Calcinosis Reduction by Pyrophosphate in SSC

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-70
SponsorSzeged University

About this trial

Calcinosis, i.e. crystal-like nodules are troublesome complication of systemic sclerosis, an autoimmune disease. Pyrophosphate inhibits its formation is laborytory. We would like to test if orally administered pyrophosphate prevents calcinosis formation.

Eligibility criteria

Qualifiers

to meet ACR/ EULAR classification criteria

Disqualifiers

severe upper minfestation of SSC

hypo- or hyperthyreoidism

QT prolongation on ECG

Trial design

Treatments tested in this trial

  • Pyrophosphate
  • Placebo

Treatment groups

60 Participants
are divided into 2 treatment groups

Locations

This trial has no locations

Sponsors and collaborators

Szeged University

Lead sponsor

Research Centre for Natural Sciences

Collaborator

University of Debrecen Dept. of Rheumatology

Collaborator